Suchergebnisse - "Bode, Bruce"

PubPharm (23)

1

Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes

enthalten in: The New England journal of medicine | 2023

von Ramos, E. | Dayan, C. | Chatenoud, L. | +109

2

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial

enthalten in: Annals of internal medicine | 2023

von Bajaj, H. | Aberle, J. | Davies, M. | +6

ErratumIn: Ann Intern Med. 2023 Nov 7;:. - PMID 37931272

3

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2) : a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Garvey, W. | Frias, J. | Jastreboff, A. | +94

CommentIn: Lancet. 2023 Aug 19;402(10402):586-588. - PMID 37385274

4

Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetes

enthalten in: Diabetes, obesity & metabolism | 2022

von Pieber, T. | Aronson, R. | Christiansen, M. | +3

5

Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes : PRONTO-Pump Study

enthalten in: Diabetes technology & therapeutics | 2021

von Bode, B. | Garg, S. | Norwood, P. | +4

6

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes : The onset 7 Trial

enthalten in: Diabetes care | 2019

von Bode, B. | Iotova, V. | Kovarenko, M. | +6

7

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7) : a multicentre, open-label, randomised, phase 3a trial

enthalten in: The lancet. Diabetes & endocrinology | 2019

von Pieber, T. | Bode, B. | Mertens, A. | +92

CommentIn: Lancet Diabetes Endocrinol. 2019 Jul;7(7):500-502. - PMID 31189516

8

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes : The North American inTandem1 Study

enthalten in: Diabetes care | 2018

von Buse, J. | Garg, S. | Rosenstock, J. | +12

9

Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1) : A 52-week, randomized, treat-to-target, phase III trial

enthalten in: Diabetes, obesity & metabolism | 2018

von Mathieu, C. | Bode, B. | Franek, E. | +5

10

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes : The onset 2 Trial

enthalten in: Diabetes care | 2017

von Bowering, K. | Case, C. | Harvey, J. | +6

CommentIn: Diabetes Care. 2018 Mar;41(3):e27-e28. - PMID 29463669